PubRank

P A Pizzo

Author PubWeight™ 275.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A 1991 4.23
2 Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. Lab Anim Sci 1988 3.49
3 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000 3.38
4 Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991 3.16
5 Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982 3.08
6 A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999 3.02
7 Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990 2.99
8 Human immunodeficiency virus infection in children. J Pediatr 1989 2.80
9 Antibiotic-resistant group JK bacteria in hospitals. J Clin Microbiol 1981 2.71
10 Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol 1995 2.51
11 From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990 2.39
12 Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J Infect Dis 1994 2.28
13 A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986 2.26
14 Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol 1979 2.13
15 Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother 1995 2.12
16 Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993 2.11
17 Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pediatr AIDS HIV Infect 1996 2.09
18 Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. J Pediatr 1990 2.07
19 Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1994 2.04
20 Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis 1988 1.95
21 Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993 1.95
22 Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annu Rev Microbiol 1988 1.92
23 Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988 1.91
24 Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988 1.90
25 Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 1995 1.86
26 Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. Am J Med 1982 1.84
27 A new tumour-derived transforming strain of Epstein-Barr virus. Nature 1978 1.84
28 Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991 1.70
29 Cancer in children with primary or secondary immunodeficiencies. J Pediatr 1995 1.70
30 Comparison of lysis-centrifugation with lysis-filtration and a conventional unvented bottle for blood cultures. J Clin Microbiol 1984 1.67
31 Cryptococcosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1996 1.66
32 Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J Pediatr 1990 1.65
33 Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppressed pediatric patients. J Pediatr 1989 1.63
34 Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother 1994 1.61
35 Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 1979 1.61
36 Stimulatory effect of counterflow centrifugal elutriation in large-scale separation of peripheral blood monocytes can be reversed by storing the cells at 37 degrees C. J Clin Apher 1991 1.61
37 Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 1978 1.60
38 A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol 1990 1.59
39 Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 1.56
40 Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med 1995 1.55
41 Smooth muscle tumors in children with human immunodeficiency virus infection. Pediatrics 1992 1.50
42 Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrob Agents Chemother 1995 1.48
43 Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 1995 1.47
44 Leptotrichia buccalis bacteremia in patients with cancer: report of four cases and review. Rev Infect Dis 1991 1.46
45 A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992 1.45
46 Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection. J Pediatr 1991 1.45
47 Pain in pediatric human immunodeficiency virus infection: incidence and characteristics in a single-institution pilot study. Pediatrics 1996 1.44
48 Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992 1.42
49 Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis. Antimicrob Agents Chemother 1991 1.41
50 Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. J Infect Dis 1990 1.41
51 Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children. J Infect Dis 1992 1.39
52 Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases. Clin Infect Dis 1992 1.38
53 Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J Infect Dis 1994 1.37
54 Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits. Antimicrob Agents Chemother 1990 1.35
55 The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med 1989 1.33
56 Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis 1986 1.32
57 Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol 1987 1.31
58 Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis 1992 1.30
59 Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits. Antimicrob Agents Chemother 1989 1.30
60 Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992 1.25
61 Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature. Clin Infect Dis 1992 1.25
62 IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997 1.24
63 Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. J Pediatr 1992 1.22
64 Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 1995 1.22
65 Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis 1996 1.21
66 Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981 1.21
67 Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis. Antimicrob Agents Chemother 1994 1.20
68 Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr 1983 1.17
69 Work-family issues and perceptions of stress among pediatric faculty and house staff. Ambul Pediatr 2002 1.16
70 Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children. Antimicrob Agents Chemother 1998 1.16
71 Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk? N Engl J Med 1975 1.15
72 Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. J Clin Microbiol 1991 1.14
73 Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrob Agents Chemother 1989 1.14
74 Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect Dis 1994 1.12
75 Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr 1989 1.12
76 Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group. J Infect Dis 1996 1.11
77 Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome. J Pediatr 1994 1.11
78 Controversies in the management of febrile neutropenic cancer patients. Cancer Invest 1988 1.10
79 Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992 1.10
80 Effects of antifungal agents on the function of human neutrophils in vitro. Antimicrob Agents Chemother 1990 1.08
81 Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrob Agents Chemother 1997 1.07
82 Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 1992 1.07
83 Approaching the controversies in antibacterial management of cancer patients. Am J Med 1984 1.06
84 Prolonged fever in children: review of 100 cases. Pediatrics 1975 1.05
85 Hepatic abscess in cancer patients. Characterization and management. Arch Surg 1993 1.05
86 Increasing incidence of Gram-positive sepsis in cancer patients. Med Pediatr Oncol 1978 1.05
87 A phase I/II study of the protease inhibitor indinavir in children with HIV infection. Pediatrics 1998 1.05
88 Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr 1989 1.05
89 Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol 1993 1.04
90 Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus. J Pediatr 1992 1.04
91 Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine (Baltimore) 1982 1.03
92 Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection. J Pediatr 1994 1.03
93 Patterns of morphologic variation among isolates of Trichosporon beigelii. J Clin Microbiol 1990 1.03
94 Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages. J Pediatr 1999 1.03
95 Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts. Rev Infect Dis 1990 1.03
96 The utility of protected-environment regimens for the compromised host: a critical assessment. Prog Hematol 1977 1.02
97 Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. Antimicrob Agents Chemother 1994 1.01
98 Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. J Pediatr 1990 0.98
99 Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy. J Clin Oncol 1996 0.98
100 Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis 1993 0.98
101 Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997 0.97
102 Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Eur J Immunol 1991 0.97
103 Staphylococcus aureus sepsis in children with cancer. Pediatrics 1978 0.97
104 Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993 0.97
105 Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1996 0.96
106 SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits. Antimicrob Agents Chemother 1990 0.96
107 Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Pediatrics 1995 0.96
108 Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine. Am J Ophthalmol 1992 0.95
109 Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids. Virology 1979 0.95
110 Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study. J Nucl Med 1989 0.95
111 Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges. Cancer 1984 0.95
112 Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma. J Infect Dis 1992 0.94
113 Multilocular thymic cysts: imaging features in children with human immunodeficiency virus infection. Radiology 1996 0.93
114 Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease. AIDS 1995 0.93
115 Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus. J Infect Dis 1993 0.93
116 Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates. Antimicrob Agents Chemother 1990 0.92
117 Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection. Pediatrics 1994 0.92
118 Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases. Curr Opin Oncol 1992 0.92
119 Emergence of Clostridium tertium as a pathogen in neutropenic patients. Am J Med 1986 0.92
120 Helper T-cell responses in children infected with human immunodeficiency virus type 1. J Pediatr 1991 0.92
121 A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses. Proc Natl Acad Sci U S A 1992 0.92
122 Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia. J Infect Dis 1988 0.92
123 Cerebral artery aneurysms in children infected with human immunodeficiency virus. J Pediatr 1992 0.91
124 Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine 1996 0.91
125 Agrobacterium radiobacter bacteremia in a child with human immunodeficiency virus infection. Pediatr Infect Dis J 1991 0.91
126 Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects. Semin Oncol 1997 0.91
127 Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr 1990 0.91
128 Quantitative relationships between zidovudine exposure and efficacy and toxicity. Antimicrob Agents Chemother 1994 0.90
129 A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection. Pediatrics 1998 0.90
130 Multilocular thymic cysts in children with human immunodeficiency virus infection: clinical and pathologic aspects. J Pediatr 1997 0.89
131 Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis 1993 0.89
132 Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J Infect Dis 1996 0.89
133 Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine. J Infect Dis 2001 0.89
134 Amphotericin B in the treatment of Candida cholecystitis. Pediatr Infect Dis J 1989 0.89
135 In the vertical transmission of HIV, timing may be everything. N Engl J Med 1991 0.88
136 Infectious complications in childhood acute leukemias. Pediatr Clin North Am 1988 0.88
137 Infectious complications in the child with cancer. II. Management of specific infectious organisms. J Pediatr 1981 0.88
138 Serum D-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. J Med Vet Mycol 1994 0.88
139 Detection of Candida casts in experimental renal candidiasis: implications for the diagnosis and pathogenesis of upper urinary tract infection. J Med Vet Mycol 1994 0.88
140 Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst 1980 0.87
141 The effect of total parenteral nutrition on chemotherapy-induced myelosuppression. A randomized study. Am J Med 1983 0.87
142 The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer 1978 0.87
143 Right lower quadrant pain in young patients with leukemia. A surgical perspective. Ann Surg 1987 0.87
144 Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy. Antimicrob Agents Chemother 1987 0.87
145 Excess prevalence of Pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapy. Ann Intern Med 1986 0.87
146 Therapy-induced dysfunction of salivary glands: implications for oral health. Spec Care Dentist 1986 0.87
147 The HIV-infected child: parental responses and psychosocial implications. Am J Orthopsychiatry 1994 0.87
148 Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995 0.87
149 Alpha-hemolytic streptococci: clinical significance in the cancer patient. Med Pediatr Oncol 1978 0.87
150 Pulmonary cryptococcosis presenting as metastases in children with sarcomas. Pediatr Infect Dis J 1993 0.87
151 Limitations of current antimicrobial therapy in the immunosuppressed host: looking at both sides of the coin. Am J Med 1984 0.86
152 Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same. Clin Infect Dis 1994 0.86
153 Microbiological evaluation of food items. For patients undergoing gastrointestinal decontamination and protected isolation. J Am Diet Assoc 1982 0.86
154 Final report of the United States Department of Health and Human Services Secretary's Work Group on pediatric human immunodeficiency virus infection and disease: content and implications. Pediatrics 1989 0.86
155 Changes in T-helper cell function in human immunodeficiency virus-infected children during didanosine therapy as a measure of antiretroviral activity. Blood 1992 0.86
156 Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. J Infect Dis 1995 0.86
157 High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids. J Chromatogr 1990 0.86
158 Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with the acquired immunodeficiency syndrome. Am J Ophthalmol 1992 0.86
159 Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J Med Vet Mycol 1996 0.85
160 NIH conference. Respiratory disease in the immunosuppressed patient. Ann Intern Med 1992 0.85
161 Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen. J Infect Dis 1994 0.85
162 Hepatosplenic candidiasis: wheels within wheels. Radiology 1988 0.85
163 Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction. J Infect Dis 1994 0.85
164 Malignancies in pediatric AIDS. Curr Opin Pediatr 1996 0.85
165 Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS. J Infect Dis 2001 0.84
166 Treatment of gram-positive septicemia in cancer patients. Cancer 1980 0.84
167 Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value. J Infect Dis 1993 0.84
168 Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J Clin Microbiol 1995 0.84
169 Individual prognoses of long-term responses to antiretroviral treatment based on virological, immunological and pharmacological parameters measured during the first week under therapy. AIDS 1998 0.84
170 Current considerations in the management of fever and neutropenia. Curr Clin Top Infect Dis 1999 0.84
171 New beta-lactam antibiotics in granulocytopenic patients. New options and new questions. Am J Med 1985 0.84
172 Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 1995 0.83
173 Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer 1978 0.83
174 Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy. J Pediatr Psychol 1994 0.83
175 High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapy. J Pediatr 1993 0.83
176 Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr 1996 0.83
177 Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection. J Infect Dis 1996 0.83
178 Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection. J Infect Dis 1999 0.83
179 After empiric therapy: what to do until the granulocyte comes back. Rev Infect Dis 1987 0.83
180 Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient. Cancer Treat Rep 1983 0.82
181 Pyomyositis in acute lymphocytic leukemia heralded by cutaneous vasculitis: brief communication. Med Pediatr Oncol 1979 0.82
182 Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy. J Acquir Immune Defic Syndr 1991 0.82
183 Oral health of pediatric AIDS patients: a hospital-based study. ASDC J Dent Child 1994 0.82
184 Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia. FEMS Immunol Med Microbiol 1997 0.82
185 Cytomegalovirus infection in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1997 0.82
186 Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeys. Antimicrob Agents Chemother 1989 0.81
187 Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy. Cancer 1977 0.81
188 Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factors. Pediatr Infect Dis J 2000 0.81
189 Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment. AIDS 1998 0.81
190 Suppression of polymorphonuclear leukocyte bactericidal activity by suramin. Antimicrob Agents Chemother 1993 0.81
191 Successful surgical management of neutropenic enterocolitis in two patients with severe aplastic anemia. Case reports and review of the literature. Arch Intern Med 1993 0.80
192 Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology 1995 0.80
193 Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep 1978 0.80
194 Will current training programs prepare pediatricians to meet the health care needs of children in the 21st century? An opinion. J Pediatr 2001 0.80
195 Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients? J Antimicrob Chemother 1986 0.80
196 Kinetics of HIV-1 RNA concentration changes in pediatric patients. Pathobiology 1996 0.79
197 Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection. J Pediatr 1992 0.79
198 The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol 1993 0.79
199 Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol 1979 0.79
200 A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: results of metabolic and survival studies. Surgery 1984 0.78
201 Management of the cancer patient with fever and prolonged neutropenia. Hematol Oncol Clin North Am 1993 0.78
202 Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. J Pediatr 1981 0.78
203 Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus. J Pediatr 1996 0.78
204 Bone marrow aspirates and biopsies in children with human immunodeficiency virus infection. J Pediatr Hematol Oncol 1996 0.78
205 The outpatient management of febrile neutropenia in cancer patients. Oncology (Williston Park) 1996 0.78
206 Clinical staging in rhabdomyosarcoma: current limitations and future prospects. J Clin Oncol 1987 0.78
207 High-performance liquid chromatographic method for the analysis of 2',3'-dideoxycytidine in human plasma. J Chromatogr 1990 0.78
208 Correlates of control in pediatric cancer patients and their families. J Pediatr Psychol 1982 0.77
209 Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection. J Pediatr 1992 0.77
210 Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals. Eur J Epidemiol 1992 0.77
211 New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibiotics. Pediatr Infect Dis 1984 0.77
212 Reversible dementia temporally associated with intraventricular therapy with methotrexate in a child with acute myelogenous leukemia. J Pediatr 1976 0.77
213 Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease. J Pediatr Psychol 1996 0.77
214 Infectious complications in the child with cancer. III. Prevention. J Pediatr 1981 0.77
215 Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. Cancer Treat Rep 1978 0.77
216 Managing infections in children with cancer. Pediatr Ann 1979 0.77
217 Children with serious illness: behavioral correlates of separation and isolation. Child Psychiatry Hum Dev 1980 0.77
218 Fever in the neutropenic host. Infect Dis Clin North Am 1996 0.77
219 In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob Agents Chemother 1994 0.77
220 CD4 status and P24 antigenemia. Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy? Am J Dis Child 1992 0.77
221 Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1991 0.77
222 Fatal hepatic necrosis after high-dose chemotherapy following haloalkane anesthesia. Cancer Treat Rep 1981 0.77
223 Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography. J Pediatr 1977 0.77
224 Fever and granulocytopenia in children with cancer: a study of 299 episodes with two treatment protocols in Brazil. Med Pediatr Oncol 1993 0.77
225 Late recurrent Candida endocarditis. Chest 1991 0.77
226 Soft tissue sarcomas in childhood. Pediatr Clin North Am 1985 0.77
227 The value of protective isolation in preventing nosocomial infections in high risk patients. Am J Med 1981 0.76
228 Monotherapy for empirical management of febrile neutropenic patients. NCI Monogr 1990 0.76
229 A clinicopathologic report of the retinal lesions associated with didanosine. Arch Ophthalmol 1994 0.76
230 Cytomegalovirus ureteritis as a cause of renal failure in a child infected with the human immunodeficiency virus. Clin Infect Dis 1995 0.76
231 Acute myelogenous leukemia in children: a preliminary report of combination chemotherapy. J Pediatr 1976 0.76
232 Controlled clinical trials of nutritional intervention as an adjunct to chemotherapy, with a comment on nutrition and drug resistance. Cancer Res 1982 0.76
233 Production of and response to interleukin-2 by cultured T cells: effects of lithium chloride and other putative modulators. J Biol Response Mod 1985 0.76
234 Conceptions of cancer: the perspectives of child and adolescent patients and their families. J Pediatr Psychol 1982 0.76
235 Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents. Pediatr Infect Dis J 1991 0.76
236 The development of a Q-sort behavioral rating procedure for pediatric HIV patients. J Pediatr Psychol 1994 0.76
237 Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin. Cancer 1984 0.75
238 Antibiotics for the treatment of febrile children with neutropenia and cancer. N Engl J Med 1989 0.75
239 Cancer in the child infected with human immunodeficiency virus. J Pediatr 1990 0.75
240 Simple and microbiologically safe portable transport unit for patients requiring protected isolation. J Clin Microbiol 1980 0.75
241 Perspectives on the use of cytokines in the management of infectious complications of cancer. Clin Infect Dis 1993 0.75
242 Progression of human immunodeficiency virus infection in children is related to the interaction of the virus, the immune system, and then some. Clin Infect Dis 1997 0.75
243 Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing. Antimicrob Agents Chemother 1998 0.75
244 Effects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function. Antimicrob Agents Chemother 1990 0.75
245 [Infectious complications from intraventricular route of administration in cancer patients]. Probl Med Wieku Rozwoj 1990 0.75
246 Pediatric AIDS: a perspective for the oncologist. Oncology (Williston Park) 1990 0.75
247 Retinal lesions in children treated with dideoxyinosine. N Engl J Med 1992 0.75
248 Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. J Pediatr 1978 0.75
249 [In vitro effect of amphotericin B on polymorphonuclear chemotaxis and large granular lymphocytes with natural killer activity]. Pathol Biol (Paris) 1987 0.75
250 The febrile neutropenic patient: newer options for empirical therapy. Haematol Blood Transfus 1990 0.75
251 The use of nucleoside analogues in the treatment of HIV-infected children. AIDS Res Hum Retroviruses 1992 0.75
252 An oral disease prevention program for patients receiving radiation and chemotherapy. J Am Dent Assoc 1985 0.75
253 Pneumonia and bacteremia by pneumococcal serotype 16 in a human immunodeficiency virus-infected child with normal serum antibody response to 23-valent pneumovax vaccine. J Infect Dis 1995 0.75
254 High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994 0.75
255 Therapy of osteogenic sarcoma: local, systemic or both? Eur J Cancer Clin Oncol 1985 0.75
256 Tolerance to single-dose dactinomycin in combination chemotherapy for solid tumors. Cancer Treat Rep 1981 0.75
257 Biologicals and hematopoietic cytokines in prevention or treatment of infections in immunocompromised hosts. Hematol Oncol Clin North Am 1993 0.75
258 Empiric antifungal therapy in the management of the febrile-granulocytopenic cancer patient. Pediatr Infect Dis 1983 0.75
259 Plasma pharmacokinetics and tissue penetration of a novel antifungal triazole, Bay R 3783, and its long-lasting active metabolite, Bay U 3625, in rabbits. J Antimicrob Chemother 1991 0.75
260 Childhood cancer--advances in the past decade. J Assoc Pediatr Oncol Nurses 1987 0.75
261 Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines. Cancer Res 1981 0.75
262 Biochemical and pharmacological factors causing induction and suppression of germination of Trichosporon beigelii. J Med Vet Mycol 1994 0.75
263 Empiric antimicrobial therapy in cancer patients. Haematol Blood Transfus 1985 0.75
264 Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J 1987 0.75
265 Management of pediatric cancer. Hosp Pract (Off Ed) 1986 0.75
266 The evolving population of immunocompromised children. Pediatr Infect Dis J 1988 0.75
267 Cytokines and biological response modifiers in the treatment of infection. Cancer Treat Res 1998 0.75
268 Aerosolized pentamidine: a well-tolerated mode of prophylaxis against Pneumocystis carinii pneumonia in older children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992 0.75
269 Meningeal relapse of orbital rhabdomyosarcoma. Med Pediatr Oncol 1978 0.75
270 Association of cytomegalovirus with acute colitis in a patient with lymphoma. Am J Pediatr Hematol Oncol 1979 0.75
271 Problems of intensive therapy in childhood cancer. Cancer 1986 0.75
272 Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol 1985 0.75
273 A blueprint for care, treatment, and prevention of HIV/AIDS in children. Pediatr Infect Dis J 1994 0.75
274 Adherence of Candida albicans to bladder mucosa: development and application of a tissue explant assay. Mycoses 1999 0.75
275 Pneumocystis carinii pneumonia (PCP) and your child: a parent information booklet. Oncol Nurs Forum 1992 0.75
276 Infection prevention strategies for children with cancer and AIDS: contrasting dilemmas. J Hosp Infect 1995 0.75
277 Optimal management of acute toxicities of therapy. Pediatr Clin North Am 1991 0.75
278 Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants. Pediatr Infect Dis J 1992 0.75
279 Disseminated intravascular coagulation associated with granulocyte colony-stimulating factor therapy in a child with human immunodeficiency virus infection. J Pediatr 1995 0.75
280 Hepatitis B surface antigen in spinal fluid. Med Pediatr Oncol 1980 0.75
281 Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection. Pediatr Infect Dis J 1996 0.75
282 Interview with Philip A. Pizzo: Isolation techniques in hospitals. Pediatr Infect Dis 1983 0.75
283 Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol 1979 0.75
284 Bacteria in food. N Engl J Med 1981 0.75
285 Continuous intravenous infusion and simultaneous pharmacokinetic monitoring in ambulatory rabbits with a programmable micropump and dual subcutaneous Silastic central venous catheters. Lab Anim Sci 1992 0.75
286 Thoracic mass lesions in immuno-incompetent patients. Chest 1982 0.75
287 Characterization of the Epstein-Barr virus isolated from a cell line derived from a patient with American Burkitt's lymphoma. Cancer Res 1981 0.75
288 Neurobehavioral manifestations of symptomatic HIV-1 disease in children: can nutritional factors play a role? J Nutr 1996 0.75
289 Parental psychological adaptation and children with HIV: a follow-up study. AIDS Patient Care 1995 0.75